● PUBLIC SYNDICATE RELEASERelease ID: mdam-sii-ano-oct-patent-license-2026
📰ECOSYSTEM IP LICENSING & ONCOLOGICAL TELEMETRYMDAM × SII × ANOvInter-Ecosystem Deal🔬OPTICAL COHERENCE TOMOGRAPHY (OCT)🍁CANADIAN BCC SURVEILLANCE
TORONTO & OTTAWA, ON — October 19, 2026 • FOR IMMEDIATE RELEASE

MetaData Asset Management Facilitates Strategic OCT Patent Ecosystem License Agreement Between Sightline Innovation (SII) and AnoSense Solutions (ANO)

ANO to Integrate SII's Optical Coherence Tomography (OCT) IP into Personal-Device Dermatology Clinic Intake System, Streamlining Longitudinal Imagery Access, Increasing Clinic Productivity, and Addressing Basal Cell Carcinoma (BCC) Surveillance Across Canada

Licensed IP Asset Pool
OCT Patent Ecosystem

MDAM-facilitated inter-ecosystem license from Sightline Innovation (SII) to AnoSense Solutions (ANO)

Core Clinical Capability
Tomographic Change Detection

Subsurface & morphological lesion delta imagery built into personal-device (iOS/Android) intake scanning

Clinic Operational Impact
Higher Clinic Productivity

Streamlined longitudinal healthcare & imagery data enables dermatology clinics to service more customers

Primary Oncological Need
Canadian BCC Surveillance

Addresses the largest oncological monitoring need in the Canadian population—skin cancer (BCC) across time

⚡Executive Transaction & Clinical Impact Summary

MetaData Asset Management (MDAM) has facilitated a strategic license agreement between Sightline Innovation Inc. (SII) and AnoSense Solutions Inc. (ANO) for SII's Optical Coherence Tomography (OCT) ecosystem of patents. ANO is deploying this IP to build tomographic change detection imagery directly into its dermatology clinic intake system—leveraging personal device change detection scanning for skin lesions to streamline longitudinal healthcare and imagery data access, boost dermatology clinic productivity to service more customers, and address the largest oncological monitoring need in the Canadian population: surveilling for skin cancer such as Basal Cell Carcinoma (BCC) across time.

TORONTO & OTTAWA, ON — October 19, 2026 — MetaData Asset Management (MDAM), a high-conviction deep-tech venture studio and sovereign intellectual property ecosystem hub, today announced that it has facilitated a strategic intellectual property license agreement between ecosystem companies Sightline Innovation Inc. (SII) and AnoSense Solutions Inc. (ANO) covering SII's foundational Optical Coherence Tomography (OCT) ecosystem of patents.

Under the terms of the MDAM-facilitated agreement, AnoSense Solutions (ANO) will utilize SII's OCT patent ecosystem to build advanced tomographic change detection imagery directly into its dermatology clinic intake system. By combining SII's patented tomographic reconstruction and optical interferometry algorithms with ANO's personal-device change detection scanning for skin lesions on standard iPhone and Android smartphones, the platform captures both surface morphology and subsurface structural evolution across sequential patient scans.

This integration provides partner dermatology clinics with streamlined, pre-triaged access to longitudinal healthcare records and high-resolution tomographic change detection imagery data prior to in-person consultations. Equipped with quantified temporal delta vectors—measuring micro-millimeter lesion boundary velocity, nodular elevation shifts, and subsurface vascular remodeling—dermatology clinics can eliminate manual intake bottlenecks, operate at a significantly higher productivity level, and service more customers with greater diagnostic precision.

Critically, the combined SII × ANO capability directly addresses the largest oncological monitoring need in the Canadian population: continuous, multi-year surveillance for skin cancer—such as Basal Cell Carcinoma (BCC)—across time. With non-melanoma skin cancers led by BCC representing the highest-incidence malignancy in Canada and placing immense strain on specialist waitlists, empowering patients to perform longitudinal personal-device lesion scanning linked directly to clinical tomographic intake enables earlier intervention, higher clinic throughput, and nationwide oncological continuity of care.

All longitudinal healthcare and tomographic imagery datasets are cryptographically attested at the mobile edge and transmitted via the open-source ZeroServer Mesh (BVS1 sovereign storage and Kuma mutual-TLS service mesh) under strict patient-consented HIPAA and Canadian PIPEDA zero-trust access controls.

"By bridging Sightline Innovation's Optical Coherence Tomography patent ecosystem with AnoSense's personal-device dermatology intake network, MetaData Asset Management is demonstrating the compounding power of our venture studio ecosystem—arming Canadian dermatology clinics with longitudinal tomographic change detection imagery so clinicians can operate at peak productivity and meet Canada's largest oncological surveillance challenge in Basal Cell Carcinoma head-on."

— Managing Syndicate Partner, MetaData Asset Management (MDAM)

🔬How SII OCT Patents Power ANO's Dermatology Clinic Intake System

End-to-end longitudinal skin lesion change detection & Basal Cell Carcinoma (BCC) surveillance pipeline

ZeroServer BVS1 & Kuma mTLS Attested
STAGE 01PATIENT MOBILE EDGE

📱Personal-Device Lesion Scanning (iPhone & Android)

Patients capture guided multi-angle skin lesion scans on standard iPhone and Android smartphones with automated optical distance calibration and Ed25519 device attestation.

STAGE 02SII LICENSED IP (US 11,449,757 B2 / OCT FAMILY)

🔬SII OCT Patent Ecosystem Tomographic Reconstruction

Licensed Sightline Innovation (SII) Optical Coherence Tomography (OCT) interferometry and neural reconstruction algorithms synthesize subsurface & morphological change detection imagery.

STAGE 03TEMPORAL DELTA TELEMETRY

📊Streamlined Longitudinal Healthcare & Imagery Data

Sequential scans are spatially integrated onto a 3D anatomical mesh, quantifying lesion boundary velocity, nodular elevation shifts, and vascular remodeling across time in BVS1 sovereign storage.

STAGE 04CANADIAN ONCOLOGY IMPACT

🩺High-Productivity Canadian Clinic Intake & BCC Surveillance

Dermatology clinics receive pre-triaged longitudinal healthcare and tomographic imagery packets—operating at higher productivity, servicing more customers, and surveilling for Basal Cell Carcinoma (BCC) across time.

🛡️ Sovereign BVS1 License & Patent Registry Attestation● VERIFIED ON ZEROSERVER MESH
FACILITATING STUDIOMetaData Asset Management (MDAM)Inter-Ecosystem Syndicate Governance
LICENSOR (IP HOLDER)Sightline Innovation Inc. (SII)SightScope™ OCT Family (12 USPTO B2 Grants)
LICENSEE (CLINICAL DEPLOYMENT)AnoSense Solutions Inc. (ANO)Dermatology Clinic Intake & BCC Surveillance
📰 ZeroServer Substack × Salesforce CRM × NK Chat × OpenJev LLM10 Site Publications • 3-Tier Access • Bidirectional :2525 Reply-To

Sovereign Publication Network, Interactive Reader & 1-to-1 AI Concierge

1. Select a Branded ZS Site Publication (0 Sovereign Feeds):
📬 Subscribe to Publications & Cross-Network Bundles

Automatically links your web session to the 4-stage ZeroServer CRM, provisions your 0x Ethereum wallet, and opens your 1-to-1 Sales Sandbox.

💬 Ask OpenJev @agent-concierge & Join Issue Chat

Other Studio & Collective Releases